35100728 31427192 27671684 35597128 30489659 27209484 30126803 35689405 30773536 33737992 30216090 27542683 35296678 27681305 27491308 29548681 33022811 33403703 35048074 35468886 32939809 30003184 31954088 32712102 30889301 32388526 34994576 3134086 - Search Results

Year	Number of Results
2015	5
2016	14
2017	11
2018	13
2019	12
2020	13
2021	10
2022	13
2023	1

1

Potentially Curative Targeted Therapy for Undifferentiated High-Grade Sarcoma Developing After Malignant Transformation of a BRAF V600E-Mutated Ameloblastic Fibroma.

Zhukov N, Mareeva Y, Konovalov D, Druy A, Grachev N, Litvinov D. Zhukov N, et al. JCO Precis Oncol. 2019 Dec;3:1-6. doi: 10.1200/PO.19.00282. JCO Precis Oncol. 2019. PMID: 35100728 No abstract available.

2

Adjunctive Strategies for Benign Maxillofacial Pathology.

Peacock ZS. Peacock ZS. Oral Maxillofac Surg Clin North Am. 2019 Nov;31(4):569-578. doi: 10.1016/j.coms.2019.07.002. Epub 2019 Aug 16. Oral Maxillofac Surg Clin North Am. 2019. PMID: 31427192 Review.

3

Durable treatment of ameloblastoma with single agent BRAFi Re: Clinical and radiographic response with combined BRAF-targeted therapy in stage 4 ameloblastoma.

Faden DL, Algazi A. Faden DL, et al. J Natl Cancer Inst. 2016 Sep 26;109(1):djw190. doi: 10.1093/jnci/djw190. Print 2017 Jan. J Natl Cancer Inst. 2016. PMID: 27671684 No abstract available.

4

Molecular biology exploration and targeted therapy strategy of Ameloblastoma.

Lu Y, Zhang X, Li X. Lu Y, et al. Arch Oral Biol. 2022 Aug;140:105454. doi: 10.1016/j.archoralbio.2022.105454. Epub 2022 May 13. Arch Oral Biol. 2022. PMID: 35597128 Free article. Review.

5

Advancements in MAPK signaling pathways and MAPK-targeted therapies for ameloblastoma: A review.

You Z, Liu SP, Du J, Wu YH, Zhang SZ. You Z, et al. J Oral Pathol Med. 2019 Mar;48(3):201-205. doi: 10.1111/jop.12807. Epub 2019 Feb 3. J Oral Pathol Med. 2019. PMID: 30489659 Review.

6

BRAF inhibitor treatment of primary BRAF-mutant ameloblastoma with pathologic assessment of response.

Tan S, Pollack JR, Kaplan MJ, Colevas AD, West RB. Tan S, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 Jul;122(1):e5-7. doi: 10.1016/j.oooo.2015.12.016. Epub 2016 Feb 23. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016. PMID: 27209484

7

Biological profile of ameloblastoma and its location in the jaw in 1246 Nigerians.

Agbaje JO, Olumuyiwa Adisa A, Ivanova Petrova M, Adenike Olusanya A, Osayomi T, Ajibola Effiom O, Oladele Soyele O, Gbenga Omitola O, Babajide Olawuyi A, Obos Okiti R, Eziafa Saiki T, Fomete B, Aremu Ibikunle A, Okwuosa C, Abimbola Olajide M, Mofoluwake Ladeji A, Emmanuel Adebiyi K, Mobola Emmanuel M, Sikiru Lawal H, Uwadia E, Oludare Fakuade B, Mohammed Abdullahi Y, Politis C. Agbaje JO, et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018 Nov;126(5):424-431. doi: 10.1016/j.oooo.2018.06.014. Epub 2018 Jul 24. Oral Surg Oral Med Oral Pathol Oral Radiol. 2018. PMID: 30126803

8

New Ameloblastoma Cell Lines Enable Preclinical Study of Targeted Therapies.

Nguyen J, Saffari PS, Pollack AS, Vennam S, Gong X, West RB, Pollack JR. Nguyen J, et al. J Dent Res. 2022 Nov;101(12):1517-1525. doi: 10.1177/00220345221100773. Epub 2022 Jun 10. J Dent Res. 2022. PMID: 35689405

9

[BRAF gene mutations in ameloblastic fibromas].

You Z, Xu LL, Li XF, Zhang JY, DU J, Sun LS. You Z, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2019 Feb 18;51(1):4-8. doi: 10.19723/j.issn.1671-167X.2019.01.002. Beijing Da Xue Xue Bao Yi Xue Ban. 2019. PMID: 30773536 Free PMC article. Chinese.

10

Molecular biological findings of ameloblastoma.

Fuchigami T, Ono Y, Kishida S, Nakamura N. Fuchigami T, et al. Jpn Dent Sci Rev. 2021 Nov;57:27-32. doi: 10.1016/j.jdsr.2020.12.003. Epub 2021 Feb 24. Jpn Dent Sci Rev. 2021. PMID: 33737992 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results